3olf
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 3olf is ON HOLD Authors: Rudolph, M.G. Description: Lead optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists f...) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3olf is ON HOLD | + | The entry 3olf is ON HOLD until Paper Publication |
Authors: Rudolph, M.G. | Authors: Rudolph, M.G. | ||
| - | Description: | + | Description: Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Sep 22 14:33:35 2010'' |
Revision as of 11:24, 22 September 2010
Unreleased structure
The entry 3olf is ON HOLD until Paper Publication
Authors: Rudolph, M.G.
Description: Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid
Page seeded by OCA on Wed Sep 22 14:33:35 2010
